APOE4 Testing Can Help You Understand Your Alzheimer's Risk

Knowing your APOE status can help you plan for your brain and heart health. Here’s what the results mean, where to get tested, and why long-term care insurance deserves a look before you order.

A family history of Alzheimer's can make a simple lab test look very appealing. Wouldn't it be better to know?

Knowing your APOE status can make an inherited risk factor more concrete and help you approach brain-health planning with greater intention. Before testing, it also helps to understand the results, your privacy, and one often-overlooked issue: long-term care insurance.

APOE testing can identify an inherited risk factor. It cannot tell your future. The best decision starts with understanding what the result would mean for you.

What Does APOE4 Actually Mean?

Everyone has the APOE gene, which helps the body transport cholesterol and other fats. Its three common versions are called APOE2, APOE3, and APOE4. You inherit one from each biological parent.

APOE4 is associated with increased risk of late-onset Alzheimer's disease. It is often called “the Alzheimer's gene,” but that nickname makes the result sound more definitive than it is.

Compared with APOE 3/3, research commonly reports:

• APOE 3/4: approximately 3–4 times higher odds of Alzheimer's.

• APOE 4/4: approximately 9–15 times higher odds of Alzheimer's.

These are comparisons between groups, not a calculation of your personal lifetime probability. Estimates vary with age, sex, ancestry, and study population.

An APOE4 result deserves attention. It does not, by itself, diagnose Alzheimer's or establish that you will develop dementia. A result without APOE4 does not rule out Alzheimer's, either.

APOE4 Also Matters for Heart Health

APOE affects more than the brain. People with APOE 3/4 or 4/4 tend to have higher LDL cholesterol and may have increased risk of coronary heart disease compared with people with APOE 3/3. The cardiovascular association is smaller and less consistent than the association with Alzheimer's.

Knowing your status can prompt a useful conversation with your healthcare team about cholesterol, blood pressure, blood sugar, smoking, physical activity, and nutrition. Decisions about medication should be based on your measured risk factors and overall cardiovascular risk, rather than APOE status alone.

That gives testing another practical purpose: information that can help you pay closer attention to modifiable risks affecting your heart and brain.

Why Someone Might Want to Know

To understand an inherited risk factor. Some people prefer having the information when discussing their family history and future plans.

To inform heart-health planning. APOE4 status can add context to a cardiovascular risk assessment and encourage timely attention to cholesterol and other modifiable factors.

To explore research participation. Certain studies use APOE status to identify eligible participants.

To strengthen their commitment to brain health. Knowing may make action feel more personally relevant.

To inform a treatment decision. For people being evaluated for certain Alzheimer's treatments, testing can have a specific medical purpose. APOE4, especially two copies, increases the risk of treatment-related brain swelling or bleeding with lecanemab.

That treatment-safety use is different from ordering a test simply to learn your risk.

What to Understand Before Testing

A result can answer one question while raising several others.

Would you interpret an APOE4 result as information you can use, or find yourself watching every misplaced key? Would a result without APOE4 make you less inclined to address other risk factors?

There can also be implications for relatives, because genetic information is shared within families. Consumer testing introduces questions about where your data are stored, who can access them, and what happens if you upload raw data to another service.

You do not have to make this decision alone. Understanding both the benefits and limitations helps you decide whether testing supports your goals.

Consider Long-Term Care Insurance Before Testing

This is easy to overlook when ordering a test online.

Long-term care insurance may help pay for assistance with daily activities or ongoing care. It is different from health insurance, and the legal protections are different, too.

The federal Genetic Information Nondiscrimination Act, known as GINA, provides protections involving genetic information in health insurance and most employment. It does not cover long-term care, life, or disability insurance.Some states provide additional protections.

Depending on state law and an insurer's rules, known genetic results may affect whether coverage is offered or what it costs.

If you are considering long-term care insurance, discuss the implications with a qualified insurance professional before elective genetic testing. Ask what information an application requires and which protections apply in your state. Answer application questions accurately; do not assume an at-home result is exempt.

This does not mean postponing evaluation of memory symptoms or a medically indicated test. It means understanding the insurance implications before testing solely out of curiosity.

Read the National Human Genome Research Institute's explanation of genetic discrimination.

Make Testing an Informed Decision

APOE testing is not a crystal ball, and professional guidance cautions against treating it as a routine prediction of who will develop Alzheimer's. That limitation is different from the personal value of understanding an inherited risk factor. Genetic counseling helps you decide how the information could support your planning.

Before testing, consider:

• What decision would this result change?

• How would I feel about either result?

• Have I considered insurance and data privacy?

• Who will help me interpret the result?

A genetic counselor can review your family history, explain the limitations, and help you decide. If several relatives developed Alzheimer's unusually young, the appropriate evaluation may involve genes other than APOE.

If you already have a consumer result, bring it to your clinician or genetic counselor before making medical decisions. If you have memory or thinking changes, seek a clinical evaluation rather than relying on genetic testing to explain them.

Where and How to Get Tested

You can arrange APOE testing through your healthcare team or initiate testing through certain consumer services. You do not always need to obtain an order from your own physician first.

Function Health. Function lists Alzheimer's Risk (ApoE) as an optional add-on for members. You can request the add-on through the service and arrange sample collection. Its process includes clinician review and ordering, so a request is subject to approval. Confirm the current fee and availability before purchasing.

LabCorp or Quest Diagnostics. These commercial diagnostic laboratories offer APOE testing with an order from your primary care clinician or neurologist. An Alzheimer’s amyloid test measures something different from APOE testing. Check whether the specific test or panel also reports APOE status.

The National Society of Genetic Counselors directory offers in-person and telehealth options for understanding your results. Ask about experience with adult Alzheimer's risk.

Before testing, confirm what the test measures, whether it reports the APOE combinations discussed here, its cost, and who will explain the result. Review privacy and long-term care insurance considerations even if you pay out of pocket.

Now That You Know, What Can You Do?

Your result can be a starting point for a plan.

Put the result in context. Review it with your clinician or genetic counselor alongside your family history and current health. If you have memory or thinking changes, arrange a clinical evaluation.

Identify the factors you can address. Work with your healthcare team to review blood pressure, cholesterol, blood sugar, sleep, hearing, medications, and other relevant concerns. Build sustainable routines for movement, nutrition, and social and cognitive engagement. Your genotype adds information; it does not replace this broader assessment.

Consider a structured program. Apollo Health's PreCODE and ReCODE programs use the Bredesen approach to develop individualized recommendations from health history, genetics, and laboratory information.

PreCODE is designed for people without cognitive symptoms who want to take a proactive approach to brain health. ReCODE is designed for people with cognitive concerns or decline and involves working with a trained medical practitioner. Carrying APOE4 alone does not mean you need ReCODE; the appropriate option depends on your clinical situation.

Get help making the plan part of daily life. Through Bloom Again Health, I coach Apollo Health PreCODE and ReCODE members as they implement the lifestyle and behavior-change components of their recommendations. I also work with adults who are not enrolled in either program.

The goal is to turn information into realistic priorities, sustainable habits, and consistent action. Coaching complements medical care; it does not replace genetic counseling, diagnosis, or treatment.

You cannot change the genes you inherited. You can use what you learn to make informed choices about the factors you can influence.

One Simple Action

Schedule a conversation with your clinician or genetic counselor about APOE testing and how the result could inform your brain-health plan. If you are considering long-term care insurance, review its implications before the test.

References

1. Yamazaki Y, Zhao N, Caulfield TR, Liu CC, Bu G. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nature Reviews Neurology. 2019;15:501–518.

2. Bennet AM, Di Angelantonio E, Ye Z, et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA. 2007;298(11):1300–1311.

3. Goldman JS, Hahn SE, Catania JW, et al. Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genetics in Medicine. 2011;13:597–605.

This article is for educational and informational purposes. It does not replace individualized medical evaluation, diagnosis, or treatment. See the complete Disclaimer.